A Multicenter, Randomized, Double-Blind Clinical Trial Examining the Effect of Oral Human Recombinant Epidermal Growth Factor on the Healing of Duodenal Ulcers
- 1 January 2000
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 35 (10) , 1016-1022
- https://doi.org/10.1080/003655200451126
Abstract
(2000). A Multicenter, Randomized, Double-Blind Clinical Trial Examining the Effect of Oral Human Recombinant Epidermal Growth Factor on the Healing of Duodenal Ulcers. Scandinavian Journal of Gastroenterology: Vol. 35, No. 10, pp. 1016-1022.Keywords
This publication has 29 references indexed in Scilit:
- Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiologyGastroenterology, 1995
- Transforming growth factor alpha and epidermal growth factor in human pancreatic cancerThe Journal of Pathology, 1991
- Epidermal Growth Factor Stimulates Synthesis and Secretion of Mucus Glycoproteins in Human Gastric MucosaClinical Science, 1990
- Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cellsNature, 1990
- Transforming growth factor α and epidermal growth factor levels in normal human gastrointestinal mucosaBritish Journal of Cancer, 1989
- Epidermal growth factor in the gastroprotective and ulcer-healing actions of sucralfate in ratsThe American Journal of Medicine, 1989
- The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological actionRegulatory Peptides, 1988
- Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucosal mucus coatBiochemical and Biophysical Research Communications, 1988
- Proliferative effects of urogastrone-EGF on the intestinal epithelium.Gut, 1987
- Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cellsJournal of Cellular Physiology, 1985